| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |